Previous studies confirmed that CD4+ T-cells can differentiate into distinct subsets with opposite functions, including blocking CD8+ T-cell activation and NK cell killing, recognizing cancer antigens, and aiding CD8+ T-cells in tumor immune responses [19, 45]. Here, CD8A is linked to cancer.